194 related articles for article (PubMed ID: 33387334)
1. Far di Necessità Virtù, using rare tubulopathies, Gitelman's and Bartter's syndromes, to inform the fight against COVID-19.
Calò LA; Davis PA
J Nephrol; 2021 Apr; 34(2):281-283. PubMed ID: 33387334
[No Abstract] [Full Text] [Related]
2. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
Koulouridis E; Koulouridis I
World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753
[TBL] [Abstract][Full Text] [Related]
3. Bartter's and Gitelman's syndrome.
Seyberth HW; Weber S; Kömhoff M
Curr Opin Pediatr; 2017 Apr; 29(2):179-186. PubMed ID: 27906863
[TBL] [Abstract][Full Text] [Related]
4. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
Calò LA; Davis PA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
[TBL] [Abstract][Full Text] [Related]
5. Gitelman's and Bartter's Syndromes: From Genetics to the Molecular Basis of Hypertension and More.
Ravarotto V; Bertoldi G; Stefanelli LF; Nalesso F; Calò LA
Kidney Blood Press Res; 2022; 47(9):556-564. PubMed ID: 35858584
[TBL] [Abstract][Full Text] [Related]
6. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases.
Favero M; Calò LA; Schiavon F; Punzi L
Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter's and Gitelman's syndrome patients.
Calò LA; Bertoldi G; Davis PA
Pharmacol Res; 2020 Aug; 158():104903. PubMed ID: 32430287
[TBL] [Abstract][Full Text] [Related]
8. The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman's and Bartter's Syndromes.
Francini F; Gobbi L; Ravarotto V; Toniazzo S; Nalesso F; Spinella P; Calò LA
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578838
[TBL] [Abstract][Full Text] [Related]
9. The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes.
Stefanelli LF; Gobbi L; Ravarotto V; Bertoldi G; Calò LA
J Hypertens; 2022 Apr; 40(4):648-649. PubMed ID: 35165247
[No Abstract] [Full Text] [Related]
10. Hypokalemic nephropathy in an adult patient with partial empty sella: a classic Bartter's syndrome, a Gitelman's syndrome or both?
Addolorato G; Ancarani F; Leggio L; Abenavoli L; de Lorenzi G; Montalto M; Staffolani E; Zannoni GF; Costanzi S; Gasbarrini G
Panminerva Med; 2006 Jun; 48(2):137-42. PubMed ID: 16953151
[TBL] [Abstract][Full Text] [Related]
11. ACE2 and prognosis of COVID-19: Insights from Bartter's and Gitelman's syndromes patients.
Calò LA; Davis PA; Rigato M; Sgarabotto L
J Med Virol; 2020 Nov; 92(11):2308-2309. PubMed ID: 32374416
[No Abstract] [Full Text] [Related]
12. ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.
Calò LA; Rigato M; Sgarabotto L; Gianesello L; Bertoldi G; Ravarotto V; Davis PA
Front Med (Lausanne); 2021; 8():647319. PubMed ID: 34017843
[TBL] [Abstract][Full Text] [Related]
13. Bartter's and Gitelman's syndromes: from gene to clinic.
Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes.
Calò LA; Maiolino G
J Endocrinol Invest; 2015 Jul; 38(7):711-6. PubMed ID: 25740064
[TBL] [Abstract][Full Text] [Related]
15. ACE2/Angiotensin 1-7 protective anti-inflammatory and antioxidant role in hyperoxic lung injury: support from studies in Bartter's and Gitelman's syndromes.
Calò LA; Rigato M; Bertoldi G
QJM; 2020 Jun; 113(6):440-441. PubMed ID: 31851364
[No Abstract] [Full Text] [Related]
16. Analyses of subjects with hypokalemic metabolic alkolosis, Gitelman's and Bartter's syndrome.
Onem Y; Kucukardali Y; Sahan B; Atasoyu EM; Ipcioğlu O; Terekeci H; Solmazgul E; Top C; Oktenli C
Ren Fail; 2008; 30(7):691-4. PubMed ID: 18704817
[TBL] [Abstract][Full Text] [Related]
17. Bartter and Gitelman syndromes.
Zieg J; Doležel Z
Cas Lek Cesk; 2022; 161(3-4):131-134. PubMed ID: 36100451
[TBL] [Abstract][Full Text] [Related]
18. Knowing the meaning of the words we use: Gitelman's syndrome or Gitelman's disease?
García-Nieto VM; Lucas-Sáez E; Monge-Zamorano M
Nefrologia (Engl Ed); 2023; 43(6):794-795. PubMed ID: 38216427
[No Abstract] [Full Text] [Related]
19. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
[No Abstract] [Full Text] [Related]
20. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome].
Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B
Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
